相关实验视频

Updated: Jun 23, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

在国家糖尿病预防计划中添加简短的持续葡萄糖监测干预措施:多方法可行性研究

Kelli M Richardson¹, Susan M Schembre², Vanessa da Silva¹

¹School of Nutritional Sciences and Wellness, College of Agriculture, Life and Environmental Sciences, University of Arizona, Tucson, Arizona, USA.

Journal of diabetes research

|June 26, 2024

概括

将持续的葡萄糖监测 (CGM) 添加到国家糖尿病预防计划 (DPP) 中,对于糖尿病前期参与者来说是可行的和可以接受的. 这种干预措施有望改善葡萄糖意识,促进生活方式的改变.

科学领域:

生活方式干预措施
预防糖尿病预防糖尿病
行为科学是一种行为科学.

背景情况:

国家糖尿病预防计划 (DPP) 旨在通过改变生活方式来预防2型糖尿病,但参与者减肥和饮食修改的成功往往是有限的.
持续的葡萄糖监测 (CGM) 有效地提高人们对饮食和活动对糖尿病患者葡萄糖的影响的认识.
将CGM整合到糖尿病前期行为干预措施中的可行性以前没有被研究过.

研究的目的:

评估将简短的CGM干预纳入亚利桑那州合作扩展国家DPP的可行性和可接受性.
探索参与者的经验,包括促进者和障碍,关于CGM在糖尿病前期预防计划中的使用.

主要方法:

一项前性研究涉及DPP参与者,他们被邀请参加一次CGM教育课程和为期10天的CGM佩戴期.
参与者反思了与高血糖事件相关的行为,并完成了接受度调查.
聚焦小组的目的是收集关于CGM实用性和用户体验的定性数据,并通过关键点摘要 (KPS) 方法进行分析.

主要成果:

高的选择参与率 (77%) 和教育会议出席率 (89%) 符合可行性基准.
CGM的接受度很高,有96%的参与者认为它应该在DPP中提供.
参与者报告使用CGM见解来实施行为改变,如饮食调整和增加体力活动.

结论:

将简短的CGM教育课程和10天的佩戴期整合到DPP中是可行的,并且被糖尿病前期的参与者接受.
CGM显示出作为一种提高自我意识和推动葡萄糖管理行为改变的工具的潜力.
需要进一步的研究来确定CGM增强的DPP干预措施对健康结果和行为改善的有效性.

更多相关视频

Simple Continuous Glucose Monitoring in Freely Moving Mice

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...